Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease | Synapse

June 18, 2014Open Access

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Loss-of-function mutations in APOC3 were associated with low levels of triglycerides and a reduced risk of ischemic cardiovascular disease. (Funded by the European Union and others.).

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Jørgensen et al. (Wed,) studied this question.

synapsesocial.com/papers/69cdfe8c3d84e1f5ff46c484 https://doi.org/https://doi.org/10.1056/nejmoa1308027

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction2012 · 503 citations
2Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge1972 · 32,498 citations
3Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in Humans2006 · 222 citations
4Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families2013 · 23 citations
5Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population2008 · 543 citations